Drug Database
J05AR02 lamivudine and abacavir
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Abacavir/Lamivudine 600 mg/300 mg film-coated tablets
- POM Abacavir/Lamivudine 600 mg/300 mg film-coated tablets
- POM Abacavir/Lamivudine 600 mg/300 mg film-coated tablets(2)
- POM Abacavir/Lamivudine 600 mg/300 mg film-coated tablets(3)
- POM Abacavir/Lamivudine Dr. Reddys 600 mg/300 mg Film-Coated Tablets
- POM Abacavir/Lamivudine Mylan 600 mg/300 mg film-coated tablets
- POM Abacavir/Lamivudine SUN 600 mg/300 mg film-coated tablets
- POM Abacavir/lamivudine Zentiva 600mg/300mg fim-coated tablets
- POM Abacavir+Lamivudine 600mg/300mg Film-coated tablets
- POM Kivexa film-coated tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).